TSX:EXEHealthcare
Does Earnings Growth And A 5% Dividend Hike Change The Bull Case For Extendicare (TSX:EXE)?
Extendicare Inc. previously reported full-year 2025 results, with sales rising to C$1.66 billion and net income increasing to C$96.66 million, alongside higher basic and diluted earnings per share from continuing operations.
At the same time, the company announced a further 5% increase to its monthly dividend to C$0.0441 per share, underscoring how management links payout decisions to what it described as sustained operating performance and a solid capital position.
Next, we’ll examine how...